What is Candel Therapeutics?

At Candel Therapeutics, our team is developing viral immunotherapies that light up and empower the immune system to fight cancer About Designed to protect patients from cancer Our investigational therapies are designed to produce a completely individualized response, specific to the patient and their cancer for long-lasting protection Platforms

What makes Candel unique?

to harness the power of our proprietary virus-based approaches and elicit a broad, potent immune response against solid tumors and their metastases. Candel’s leadership is made up of renowned drug developers, viral immunotherapy experts, oncologists, immunologists and biotech business leaders.

How much is Candel Therapeutics worth?

At the midpoint of the proposed range, Candel Therapeutics would command a fully diluted market value of $398 million. Candel's most advanced candidate, CAN-2409, is an off-the-shelf adenovirus product candidate combined with the prodrug valacyclovir.